Human IgA Fc receptor FcαRI (CD89) triggers different forms of neutrophil death depending on the inflammatory microenvironment

Journal of Immunology

Volumn 193, Issue 11, 2014, Pages 5649-5659

  Wehrli, Marc ^a   Cortinas Elizondo, Fabiola ^a   Hlushchuk, Ruslan ^b   Daudel, Fritz ^c   Villiger, Peter M ^d   Miescher, Sylvia ^e   Zuercher, Adrian W ^e   Djonov, Valentin ^b   Simon, Hans Uwe ^a   Von Gunten, Stephan ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

^c Spital Netz Bern   (Switzerland)

^d UNIVERSITY OF BERN   (Switzerland)

^e CSL Behring AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE; FC RECEPTOR; FC RECEPTOR I; IMMUNOGLOBULIN A; IMMUNOGLOBULIN A1; IMMUNOGLOBULIN A2; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; UNCLASSIFIED DRUG; AUTACOID; CYTOKINE; FC(ALPHA) RECEPTOR; LEUKOCYTE ANTIGEN; MONOCLONAL ANTIBODY; TOLL LIKE RECEPTOR;

APOPTOSIS; ARTICLE; CELL DEATH; CELL MEMBRANE; CELL SURFACE; CELL VACUOLE; CELL VIABILITY; COCULTURE; CONTROLLED STUDY; CYTOPLASM; HUMAN; HUMAN CELL; INFLAMMATION; MACROPHAGE; MITOCHONDRION SWELLING; NEUTROPHIL; RHEUMATOID ARTHRITIS; SEPSIS; SIGNAL TRANSDUCTION; UPREGULATION; AGONISTS; CELL CULTURE; DRUG EFFECTS; IMMUNOLOGY; INNATE IMMUNITY; METABOLISM; TUMOR MICROENVIRONMENT;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD; CELL DEATH; CELLS, CULTURED; CELLULAR MICROENVIRONMENT; COCULTURE TECHNIQUES; CYTOKINES; HUMANS; IMMUNITY, INNATE; INFLAMMATION MEDIATORS; MACROPHAGES; MAP KINASE SIGNALING SYSTEM; NEUTROPHILS; PHOSPHATIDYLINOSITOL 3-KINASES; RECEPTORS, FC; TOLL-LIKE RECEPTORS;

EID: 84912554711     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1400028     Document Type: Article

References (54)

1. Bratton, D. L., and P. M. Henson. 2011. Neutrophil clearance: when the party is over, clean-up begins. Trends Immunol. 32: 350-357.
2. Geering, B., C. Stoeckle, S. Conus, and H.-U. Simon. 2013. Living and dying for inflammation: neutrophils, eosinophils, basophils. Trends Immunol. 34: 398-409.
3. Simon, D., H. U. Simon, and S. Yousefi. 2013. Extracellular DNA traps in allergic, infectious, and autoimmune diseases. Allergy 68: 409-416.
4. Amulic, B., C. Cazalet, G. L. Hayes, K. D. Metzler, and A. Zychlinsky. 2012. Neutrophil function: from mechanisms to disease. Annu. Rev. Immunol. 30: 459-489.
5. Mantovani, A., M. A. Cassatella, C. Costantini, and S. Jaillon. 2011. Neutrophils in the activation and regulation of innate and adaptive immunity. Nat. Rev. Immunol. 11: 519-531.
6. Brown, K. A., S. D. Brain, J. D. Pearson, J. D. Edgeworth, S. M. Lewis, and D. F. Treacher. 2006. Neutrophils in development of multiple organ failure in sepsis. Lancet 368: 157-169.
7. Wright, H. L., R. J. Moots, R. C. Bucknall, and S. W. Edwards. 2010. Neutrophil function in inflammation and inflammatory diseases. Rheumatology (Oxford) 49: 1618-1631.
8. Cohen, T. S., and A. Prince. 2012. Cystic fibrosis: a mucosal immunodeficiency syndrome. Nat. Med. 18: 509-519.
9. Bosch, X. 2011. Systemic lupus erythematosus and the neutrophil. N. Engl. J. Med. 365: 758-760.
10. von Gunten, S., Y. Shoenfeld, M. Blank, D. R. Branch, T. Vassilev, F. Käsermann, J. Bayry, S. Kaveri, and H. U. Simon. 2014. IVIG pluripotency and the concept of Fc-sialylation: challenges to the scientist. Nat. Rev. Immunol. 14: 349.
11. von Gunten, S., and H. U. Simon. 2010. Cell death modulation by intravenous immunoglobulin. J. Clin. Immunol. 30(Suppl. 1): S24-S30.
12. von Gunten, S., A. Schaub, M. Vogel, B. M. Stadler, S.Miescher, and H. U. Simon. 2006. Immunologic and functional evidence for anti-Siglec-9 autoantibodies in intravenous immunoglobulin preparations. Blood 108: 4255-4259.
13. Schaub, A., S. von Gunten, M. Vogel, S. Wymann, M. Rüegsegger, B. M. Stadler, M. Spycher, H. U. Simon, and S. Miescher. 2011. Dimeric IVIG contains natural anti-Siglec-9 autoantibodies and their anti-idiotypes. Allergy 66: 1030-1037.
14. Altznauer, F., S. von Gunten, P. Späth, and H. U. Simon. 2003. Concurrent presence of agonistic and antagonistic anti-CD95 autoantibodies in intravenous Ig preparations. J. Allergy Clin. Immunol. 112: 1185-1190.
15. von Gunten, S., M. Vogel, A. Schaub, B. M. Stadler, S. Miescher, P. R. Crocker, and H. U. Simon. 2007. Intravenous immunoglobulin preparations contain anti-Siglec-8 autoantibodies. J. Allergy Clin. Immunol. 119: 1005-1011.
16. Bakema, J. E., and M. van Egmond. 2011. The human immunoglobulin A Fc receptor FcαRI: a multifaceted regulator of mucosal immunity. Mucosal Immunol. 4: 612-624.
17. Herr, A. B., E. R. Ballister, and P. J. Bjorkman. 2003. Insights into IgA-mediated immune responses from the crystal structures of human FcalphaRI and its complex with IgA1-Fc. Nature 423: 614-620.
18. Delacroix, D. L., H. J. Hodgson, A. McPherson, C. Dive, and J. P. Vaerman. 1982. Selective transport of polymeric immunoglobulin A in bile. Quantitative relationships of monomeric and polymeric immunoglobulin A, immunoglobulin M, and other proteins in serum, bile, and saliva. J. Clin. Invest. 70: 230-241.
19. Pasquier, B., P. Launay, Y. Kanamaru, I. C. Moura, S. Pfirsch, C. Ruffié, D. Hénin, M. Benhamou, M. Pretolani, U. Blank, and R. C. Monteiro. 2005. Identification of FcalphaRI as an inhibitory receptor that controls inflammation: dual role of FcRgamma ITAM. Immunity 22: 31-42.
20. Schettini, J., G. Salamone, A. Trevani, S. Raiden, R. Gamberale, M. Vermeulen, M. Giordano, and J. R. Geffner. 2002. Stimulation of neutrophil apoptosis by immobilized IgA. J. Leukoc. Biol. 72: 685-691.
21. Aleyd, E., M. W. van Hout, S. H. Ganzevles, K. A. Hoeben, V. Everts, J. E. Bakema, and M. van Egmond. 2014. IgA enhances NETosis and release of neutrophil extracellular traps by polymorphonuclear cells via Fcα receptor I. J. Immunol. 192: 2374-2383.
22. von Gunten, S., S. Yousefi, M. Seitz, S. M. Jakob, T. Schaffner, R. Seger, J. Takala, P. M. Villiger, and H. U. Simon. 2005. Siglec-9 transduces apoptotic and nonapoptotic death signals into neutrophils depending on the proinflammatory cytokine environment. Blood 106: 1423-1431.
23. von Gunten, S., and H. U. Simon. 2006. Sialic acid binding immunoglobulin-like lectins may regulate innate immune responses by modulating the life span of granulocytes. FASEB J. 20: 601-605.
24. von Gunten, S., S. M. Jakob, B. Geering, J. Takala, and H. U. Simon. 2009. Different patterns of Siglec-9-mediated neutrophil death responses in septic shock. Shock 32: 386-392.
25. von Gunten, S., and H. U. Simon. 2007. Autophagic-like cell death in neutrophils induced by autoantibodies. Autophagy 3: 67-68.
26. Levy, M. M., M. P. Fink, J. C. Marshall, E. Abraham, D. Angus, D. Cook, J. Cohen, S. M. Opal, J. L. Vincent, and G. Ramsay, SCCM/ESICM/ACCP/ATS/ SIS. 2003. 2001 SCCM/ESICM/ACCP/ATS/SIS International sepsis definitions conference. Crit. Care Med. 31: 1250-1256.
27. Liu, B.-S., H. L. Janssen, and A. Boonstra. 2011. IL-29 and IFNa differ in their ability to modulate IL-12 production by TLR-activated human macrophages and exhibit differential regulation of the IFNγ receptor expression. Blood 117: 2385-2395.
28. Fadok, V. A., D. L. Bratton, A. Konowal, P. W. Freed, J. Y. Westcott, and P. M. Henson. 1998. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. J. Clin. Invest. 101: 890-898.
29. Lucas, M., L. M. Stuart, J. Savill, and A. Lacy-Hulbert. 2003. Apoptotic cells and innate immune stimuli combine to regulate macrophage cytokine secretion. J. Immunol. 171: 2610-2615.
30. Mihalache, C. C., S. Yousefi, S. Conus, P. M. Villiger, E. M. Schneider, and H.-U. Simon. 2011. Inflammation-associated autophagy-related programmed necrotic death of human neutrophils characterized by organelle fusion events. J. Immunol. 186: 6532-6542.
31. Monteiro, R. C., H. Kubagawa, and M. D. Cooper. 1990. Cellular distribution, regulation, and biochemical nature of an Fc alpha receptor in humans. J. Exp. Med. 171: 597-613.
32. Weisbart, R. H., A. Kacena, A. Schuh, and D. W. Golde. 1988. GM-CSF induces human neutrophil IgA-mediated phagocytosis by an IgA Fc receptor activation mechanism. Nature 332: 647-648.
33. Daigle, I., S. Yousefi, M. Colonna, D. R. Green, and H. U. Simon. 2002. Death receptors bind SHP-1 and block cytokine-induced anti-apoptotic signaling in neutrophils. Nat. Med. 8: 61-67.
34. Nutku, E., H. Aizawa, S. A. Hudson, and B. S. Bochner. 2003. Ligation of Siglec-8: a selective mechanism for induction of human eosinophil apoptosis. Blood 101: 5014-5020.
35. Geering, B., U. Gurzeler, E. Federzoni, T. Kaufmann, and H.-U. Simon. 2011. A novel TNFR1-triggered apoptosis pathway mediated by class IA PI3Ks in neutrophils. Blood 117: 5953-5962.
36. Kanamaru, Y., S. Pfirsch, M. Aloulou, F. Vrtovsnik, M. Essig, C. Loirat, G. Deschê nes, C. Gué rin-Marchand, U. Blank, and R. C. Monteiro. 2008. Inhibitory ITAM signaling by Fc alpha RI-FcR gamma chain controls multiple activating responses and prevents renal inflammation. J. Immunol. 180: 2669-2678.
37. Pfirsch-Maisonnas, S., M. Aloulou, T. Xu, J. Claver, Y. Kanamaru, M. Tiwari, P. Launay, R. C. Monteiro, and U. Blank. 2011. Inhibitory ITAM signaling traps activating receptors with the phosphatase SHP-1 to form polarized "inhibisome" clusters. Sci. Signal. 4: ra24.
38. Geering, B., and H. U. Simon. 2011. Peculiarities of cell death mechanisms in neutrophils. Cell Death Differ. 18: 1457-1469.
39. Simon, H. U., A. Haj-Yehia, and F. Levi-Schaffer. 2000. Role of reactive oxygen species (ROS) in apoptosis induction. Apoptosis 5: 415-418.
40. Savill, J., I. Dransfield, C. Gregory, and C. Haslett. 2002. A blast from the past: clearance of apoptotic cells regulates immune responses. Nat. Rev. Immunol. 2: 965-975.
41. Serhan, C. N., and J. Savill. 2005. Resolution of inflammation: the beginning programs the end. Nat. Immunol. 6: 1191-1197.
42. Savill, J., and V. Fadok. 2000. Corpse clearance defines the meaning of cell death. Nature 407: 784-788.
43. Friggeri, A., S. Banerjee, N. Xie, H. Cui, A. De Freitas, M. Zerfaoui, H. Dupont, E. Abraham, and G. Liu. 2012. Extracellular histones inhibit efferocytosis. Mol. Med. 18: 825-833.
44. Chiamolera, M., P. Launay, V. Montenegro, M. C. Rivero, I. T. Velasco, and R. C. Monteiro. 2001. Enhanced expression of Fc alpha receptor I on blood phagocytes of patients with gram-negative bacteremia is associated with tyrosine phosphorylation of the FcR-gamma subunit. Shock 16: 344-348.
45. Vercammen, D., R. Beyaert, G. Denecker, V. Goossens, G. Van Loo, W. Declercq, J. Grooten, W. Fiers, and P. Vandenabeele. 1998. Inhibition of caspases increases the sensitivity of L929 cells to necrosis mediated by tumor necrosis factor. J. Exp. Med. 187: 1477-1485.
46. Vercammen, D., G. Brouckaert, G. Denecker, M. Van de Craen, W. Declercq, W. Fiers, and P. Vandenabeele. 1998. Dual signaling of the Fas receptor: initiation of both apoptotic and necrotic cell death pathways. J. Exp. Med. 188: 919-930.
47. Kanamaru, Y., H. Tamouza, S. Pfirsch, D. El-Mehdi, C. Gué rin-Marchand, M. Pretolani, U. Blank, and R. C. Monteiro. 2007. IgA Fc receptor I signals apoptosis through the FcRgamma ITAM and affects tumor growth. Blood 109: 203-211.
48. Ben Mkaddem, S., E. Rossato, N. Heming, and R. C. Monteiro. 2013. Anti-inflammatory role of the IgA Fc receptor (CD89): from autoimmunity to therapeutic perspectives. Autoimmun. Rev. 12: 666-669.
49. Blank, U., P. Launay, M. Benhamou, and R. C. Monteiro. 2009. Inhibitory ITAMs as novel regulators of immunity. Immunol. Rev. 232: 59-71.
50. Cunningham-Rundles, C. 2010. How I treat common variable immune deficiency. Blood 116: 7-15.
51. Quinti, I., A. Soresina, G. Spadaro, S.Martino, S. Donnanno, C. Agostini, P. Claudio, D. Franco, A. Maria Pesce, F. Borghese, et al; Italian Primary Immunodeficiency Network. 2007. Long-term follow-up and outcome of a large cohort of patients with common variable immunodeficiency. J. Clin. Immunol. 27: 308-316.
52. von Gunten, S., D. F. Smith, R. D. Cummings, S. Riedel, S. Miescher, A. Schaub, R. G. Hamilton, and B. S. Bochner. 2009. Intravenous immunoglobulin contains a broad repertoire of anticarbohydrate antibodies that is not restricted to the IgG2 subclass. J. Allergy Clin. Immunol. 123: 1268-1276, e15.
53. Stowell, S. R., C. M. Arthur, R. McBride, O. Berger, N. Razi, J. Heimburg-Molinaro, L. C. Rodrigues, J.-P. Gourdine, A. J. Noll, S. von Gunten, et al. 2014. Microbial glycan microarrays define key features of host-microbial interactions. Nat. Chem. Biol. 10: 470-476.
54. Gelfand, E. W. 2012. Intravenous immune globulin in autoimmune and inflammatory diseases. N. Engl. J. Med. 367: 2015-2025.